Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Gita Fulwiler had always been an early riser -- up and moving at the crack of dawn.But in June 2023, she started struggling ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Inadequate water intake can dry out the mucosal lining in the lungs, making them more irritated and prone to infection.

American Lung Association's 2025 "State of the Air" report found Detroit with the sixth-worst year-round particle pollution in the nation. The report gives Detroit failing grades for ground-level ...

WASHINGTON (7News) — The Director of Advocacy at the American Lung Association (ALA) Aleks Casper discusses the "State of the Air" report that breaks down how the air quality affects local ...

Please provide your email address to receive an email when new articles are posted on . “Currently, clinicians may not automatically think of diet as an intervention for lung health, but growing ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. “There is no such thing as an innocent map,” observes Philippe Rekacewicz in his catalogue essay that ...

Almost half of everyone who lives in the United States breathes unhealthy levels of air pollution, according to the American Lung Association's annual State of the Air report, released Wednesday.

While current models, such as HEp-2 cells, are commonly used for RSV research, they do not accurately mimic the complex responses of the human respiratory system. The researchers aimed to evaluate ...

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...

advanced PD-L1-positive non-small cell lung cancer (NSCLC). "We evaluate our clinical programmes to focus our resources on the most promising clinically differentiated candidates while ...